4927 results
Keyword EPAR Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Rybrevant (updated)
amivantamab, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 09/12/2021,
, 
, Revision: 2, Authorised, Last updated: 30/11/2023
Rybrevant : EPAR - Medicine Overview (PDF/110.02 … -
List item
Press release: EPAR summaries for the public: A further step for the provision of better information about medicines
Last updated: 02/02/2009EPAR summaries for the public … public assessment reports (EPARs) that are specially written … the general public. These 'EPAR summaries for the public' … -
List item
Press release: European Medicines Agency and EUnetHTA Joint Action start collaboration on European Public Assessment Report (EPAR) contribution to relative effectiveness assessments
Last updated: 16/02/2010Public Assessment Report (EPAR) contribution to relative … Public Assessment Report (EPAR) contribution to relative … Public Assessment Report (EPAR) contribution to relative … -
List item
National expert: Gualberto Gussoni, European Medicines Agency (updated)
- Declaration of interests - 81.18 KB | PDF
- Curriculum Vitae - 30.39 KB | PDF
del tromboembolismo venoso: eparina non frazionata eparine a basso peso molecolare … -
List item
Human medicine European public assessment report (EPAR): Macugen
pegaptanib, Wet Macular Degeneration
Date of authorisation: 31/01/2006, Revision: 15, Withdrawn, Last updated: 02/12/2022Summary documents Macugen : EPAR - Summary for the public … Public Assessment Report (EPAR) for Macugen will be updated … -
List item
Human medicine European public assessment report (EPAR): Busilvex (updated)
busulfan, Hematopoietic Stem Cell Transplantation
Date of authorisation: 09/07/2003, Revision: 20, Withdrawn, Last updated: 27/01/2023Summary documents Busilvex : EPAR - Summary for the public … EMA/500878/2014 Generic This EPAR was last updated on 27/01/2023 … IAIN/0035/G Busilvex : EPAR - Product Information PDF … -
List item
Human medicine European public assessment report (EPAR): Xolair (updated)
omalizumab, Asthma; Urticaria
Date of authorisation: 25/10/2005, Revision: 44, Authorised, Last updated: 01/02/2023Summary documents Xolair : EPAR - Medicine overview PDF icon … -
List item
Human medicine European public assessment report (EPAR): Temybric Ellipta
fluticasone furoate, umeclidinium bromide, vilanterol trifenatate, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 12/06/2019,, Revision: 4, Withdrawn, Last updated: 24/11/2022
documents Temybric Ellipta : EPAR - Medicine overview PDF icon … Generic Temybric Ellipta : EPAR - Risk-management-plan summary … 23/09/2019 24/11/2022 Generic This EPAR was last updated on 24/11/2022 … -
List item
Human medicine European public assessment report (EPAR): Repatha (updated)
Evolocumab, Dyslipidemias; Hypercholesterolemia
Date of authorisation: 17/07/2015, Revision: 23, Authorised, Last updated: 23/01/2023Repatha : EPAR - All Authorised presentations … -
List item
Human medicine European public assessment report (EPAR): Synflorix (updated)
Pneumococcal polysaccharide serotype 23F, Pneumococcal polysaccharide serotype 4, Pneumococcal polysaccharide serotype 5, Pneumococcal polysaccharide serotype 6B, Pneumococcal polysaccharide serotype 7F, Pneumococcal polysaccharide serotype 9V, Pneumococcal polysaccharide serotype 1, Pneumococcal polysaccharide serotype 14, Pneumococcal polysaccharide serotype 18C, Pneumococcal polysaccharide serotype 19F, Pneumococcal Infections; Immunization
Date of authorisation: 29/03/2009, Revision: 35, Authorised, Last updated: 30/01/2023information. Abbreviated as EPAR. More information can be found … public assessment report (EPAR) for Synflorix. It explains … EMA/746787/2017 EMEA/H/C/000973 EPAR summary for the public … -
List item
Human medicine European public assessment report (EPAR): Humira
adalimumab, Spondylitis, Ankylosing; Arthritis, Juvenile Rheumatoid; Uveitis; Colitis, Ulcerative; Psoriasis; Arthritis, Psoriatic; Crohn Disease; Arthritis, Rheumatoid
Date of authorisation: 08/09/2003, Revision: 89, Authorised, Last updated: 16/12/2022Humira : EPAR - All Authorised presentations … -
List item
Human medicine European public assessment report (EPAR): Bexsero (updated)
outer membrane vesicles from neisseria meningitidis group b (strain nz 98/254), recombinant Neisseria meningitidis group B fHbp fusion protein, recombinant Neisseria meningitidis group B NadA protein, recombinant Neisseria meningitidis group B NHBA fusion protein, Meningitis, Meningococcal
Date of authorisation: 13/01/2013, Revision: 30, Authorised, Last updated: 25/01/2023Bexsero : EPAR - Summary for the public … -
List item
Veterinary medicine European public assessment report (EPAR): Nobilis OR Inac
inactivated whole cell suspension of Ornithobacterium rhinotracheale serotype A, strain B3263/91, Chicken
Date of authorisation: 24/01/2003, Revision: 7, Withdrawn, Last updated: 03/10/2022documents Nobilis OR Inac : EPAR - Summary for the public … PUBLIC ASSESSMENT REPORT (EPAR) NOBILIS OR INAC EPAR summary for the public … Discussion (also part of the EPAR). What is Nobilis OR Inac … -
List item
Human medicine European public assessment report (EPAR): Rasilez (updated)
aliskiren, Hypertension
Date of authorisation: 22/08/2007, Revision: 26, Authorised, Last updated: 23/01/2023public assessment report (EPAR) for Rasilez. It explains … leaflet (also part of the EPAR) or contact your doctor or … Summary documents Rasilez : EPAR - Summary for the public … -
List item
Human medicine European public assessment report (EPAR): Menveo (updated)
meningococcal group A, C, W-135 and Y conjugate vaccine, Immunization; Meningitis, Meningococcal
Date of authorisation: 15/03/2010,
Date of refusal: 17/12/2009, Revision: 32, Authorised, Last updated: 30/01/2023information. Abbreviated as EPAR. More information can be found … public assessment report (EPAR) for Menveo. It explains … leaflet (also part of the EPAR) or contact your doctor or … -
List item
Human medicine European public assessment report (EPAR): Tesavel (updated)
sitagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 10/01/2008, Revision: 27, Authorised, Last updated: 02/02/2023public assessment report (EPAR) for Tesavel. It explains … leaflet (also part of the EPAR) or contact your doctor or … Summary documents Tesavel : EPAR - Summary for the public … -
List item
Human medicine European public assessment report (EPAR): Xarelto (updated)
rivaroxaban, Arthroplasty, Replacement; Venous Thromboembolism
Date of authorisation: 30/09/2008, Revision: 39, Authorised, Last updated: 18/01/2023Summary documents Xarelto : EPAR - Medicine overview PDF icon … -
List item
Human medicine European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna) (updated)
CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2), COVID-19 virus infection
Date of authorisation: 06/01/2021,
, , Revision: 35, Authorised, Last updated: 03/02/2023
COVID-19 Vaccine Moderna): EPAR - All authorised presentations … -
List item
Veterinary medicine European public assessment report (EPAR): Activyl Tick Plus
indoxacarb, permethrin, Dogs
Date of authorisation: 09/01/2012, Revision: 9, Withdrawn, Last updated: 04/10/2022documents Activyl Tick Plus : EPAR - Medicine overview PDF icon … -
List item
Human medicine European public assessment report (EPAR): Metalyse (updated)
tenecteplase, Myocardial Infarction
Date of authorisation: 23/02/2001, Revision: 22, Authorised, Last updated: 23/01/2023information. Abbreviated as EPAR. More information can be found … public assessment report (EPAR). It explains how the The … leaflet (also part of the EPAR) or contact your doctor or … -
List item
Human medicine European public assessment report (EPAR): Toviaz (updated)
fesoterodine fumarate, Urinary Bladder, Overactive
Date of authorisation: 20/04/2007, Revision: 27, Authorised, Last updated: 11/01/2023information. Abbreviated as EPAR. More information can be found … public assessment report (EPAR) for Toviaz. It explains … characteristics (also part of the EPAR) for full details. How does … -
List item
Human medicine European public assessment report (EPAR): Helicobacter Test INFAI (updated)
urea (13C), Breath Tests; Helicobacter Infections
Date of authorisation: 14/08/1997, Revision: 20, Authorised, Last updated: 02/02/2023information. Abbreviated as EPAR. More information can be found … public assessment report (EPAR). It explains how the The … leaflet (also part of the EPAR) or contact your doctor or … -
List item
Human medicine European public assessment report (EPAR): ellaOne (updated)
ulipristal, Contraception, Postcoital
Date of authorisation: 15/05/2009, Revision: 27, Authorised, Last updated: 02/02/2023information. Abbreviated as EPAR. More information can be found … public assessment report (EPAR) for ellaOne. It explains … leaflet (also part of the EPAR) or contact your doctor or … -
List item
Human medicine European public assessment report (EPAR): Xelevia (updated)
sitagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 21/03/2007, Revision: 37, Authorised, Last updated: 31/01/2023information. Abbreviated as EPAR. More information can be found … public assessment report (EPAR) for Xelevia. It explains … leaflet (also part of the EPAR) or contact your doctor or … -
List item
Human medicine European public assessment report (EPAR): Optruma (updated)
raloxifene hydrochloride, Osteoporosis, Postmenopausal
Date of authorisation: 05/08/1998, Revision: 26, Authorised, Last updated: 30/01/2023information. Abbreviated as EPAR. More information can be found … public assessment report (EPAR). It explains how the The … leaflet (also part of the EPAR) or contact your doctor or …